Six studies at a glance
The fictional sponsors, compounds and sites are invented; the evidence behind every expectation is real. Data to September 30th 2026.
Open a study
Each study opens on its Overview, with tabs for its sites, KPIs, KRIs, QTLs, plan, design and risks. EPI-214 shows the most: a study well under way, behind its deadline, with a QTL outside its limit.
- Start here
EPI-214: Heart failure with reduced ejection fraction
Recruiting. Cardiovascular. 472 of 824 randomised.
11 months late
Red on KRIs and QTLs.
EPI-301: Non-small cell lung cancer, second line
Recruiting. Oncology. 171 of 400 randomised.
On time
EPI-118: Treatment-resistant major depressive disorder
Start-up. CNS and psychiatry. 0 of 243 randomised.
On time
EPI-405: A rare inherited neuromuscular disorder (genetically confirmed)
Recruiting. Rare disease. 7 of 64 randomised.
41 months late
Red on enrolment.
The portfolio
- Patients randomised1,121across four studies
- Sites open297in four running studies
- Running studies with a red area2 of 4EPI-214, EPI-405
| Show countries | Study | Randomised | Finish | Enrolment | Sites | KRIs | QTLs |
|---|---|---|---|---|---|---|---|
| EPI-301Non-small cell lung cancer, second lineRecruiting. Oncology | 171 of 400 | On time | 82% of plan | 5 of 10 behind | 19 of 159 flagged | All 4 within | |
| EPI-214Heart failure with reduced ejection fractionRecruiting. Cardiovascular | 472 of 824 | 11 months late | 91% of plan | 60 of 113 behind | 33 of 120 flagged | 1 of 4 outside | |
| EPI-118Treatment-resistant major depressive disorderStart-up. CNS and psychiatry | 0 of 243 | On time | Too early | Too early | 0 of 135 flagged | Too early | |
| EPI-405A rare inherited neuromuscular disorder (genetically confirmed)Recruiting. Rare disease | 7 of 64 | 41 months late | 47% of plan | Too early | 0 of 18 flagged | Too early | |
| EPI-512Moderate to severe ulcerative colitisRecruitment complete. Immunology and GI | 471 of 471 | Complete | 94% of plan | 40 of 70 behind | 31 of 70 flagged | All 4 within | |
| EPI-620Chronic obstructive pulmonary disease with frequent exacerbationsPlanning. Respiratory | 0 of 706 | In planning | No sites yet | No sites yet | No sites yet | No sites yet |
Expand a row to see its countries without leaving the page; a status opens the tab behind it. Every colour comes from a threshold in the data with its basis, listed on the References page.